Skip to main content
Invea Therapeutics, Inc. (INAI)
Invea Therapeutics was planning to go public, but the IPO was withdrawn on Mar 29, 2024.
Stock Price: Pending
IPO price not available yet

Invea Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20222021
Net Income
-5.75-3.62
Depreciation & Amortization
0-
Share-Based Compensation
0.20.08
Other Operating Activities
0.30.44
Operating Cash Flow
-5.25-3.09
Capital Expenditures
-0.01-0.01
Investing Cash Flow
-0.01-0.01
Share Issuance / Repurchase
4.872.66
Debt Issued / Paid
0.650.76
Financing Cash Flow
5.523.42
Net Cash Flow
0.260.32
Free Cash Flow
-5.26-3.1
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).